BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24268404)

  • 1. Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.
    Christensen B; Sørensen ES
    J Dairy Sci; 2014; 97(1):136-46. PubMed ID: 24268404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.
    Christensen B; Schack L; Kläning E; Sørensen ES
    J Biol Chem; 2010 Mar; 285(11):7929-37. PubMed ID: 20071328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal modification of osteopontin inhibits interaction with the αVβ3-integrin.
    Christensen B; Kläning E; Nielsen MS; Andersen MH; Sørensen ES
    J Biol Chem; 2012 Feb; 287(6):3788-97. PubMed ID: 22179617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis and immunodetection of the bovine milk osteopontin isoforms.
    Bissonnette N; Dudemaine PL; Thibault C; Robitaille G
    J Dairy Sci; 2012 Feb; 95(2):567-79. PubMed ID: 22281321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milk osteopontin retains integrin-binding activity after in vitro gastrointestinal transit.
    Christensen B; Karlsen NJ; Jørgensen SDS; Jacobsen LN; Ostenfeld MS; Petersen SV; Müllertz A; Sørensen ES
    J Dairy Sci; 2020 Jan; 103(1):42-51. PubMed ID: 31733850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.
    Jürets A; Le Bras M; Staffler G; Stein G; Leitner L; Neuhofer A; Tardelli M; Turkof E; Zeyda M; Stulnig TM
    PLoS One; 2016; 11(2):e0148333. PubMed ID: 26840958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
    Gao YA; Agnihotri R; Vary CP; Liaw L
    Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
    Zhao L; Leung LL; Morser J
    Methods Mol Biol; 2024; 2747():95-117. PubMed ID: 38038935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragment.
    Shao Z; Morser J; Leung LLK
    J Biol Chem; 2014 Sep; 289(39):27146-27158. PubMed ID: 25112870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
    Yamaguchi Y; Shao Z; Sharif S; Du XY; Myles T; Merchant M; Harsh G; Glantz M; Recht L; Morser J; Leung LL
    J Biol Chem; 2013 Feb; 288(5):3097-111. PubMed ID: 23204518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.
    Senger DR; Perruzzi CA
    Biochim Biophys Acta; 1996 Nov; 1314(1-2):13-24. PubMed ID: 8972713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regulated interaction between alpha5beta1 integrin and osteopontin.
    Barry ST; Ludbrook SB; Murrison E; Horgan CM
    Biochem Biophys Res Commun; 2000 Jan; 267(3):764-9. PubMed ID: 10673366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM20C phosphorylation of the RGDSVVYGLR motif in osteopontin inhibits interaction with the αvβ3 integrin.
    Schytte GN; Christensen B; Bregenov I; Kjøge K; Scavenius C; Petersen SV; Enghild JJ; Sørensen ES
    J Cell Biochem; 2020 Dec; 121(12):4809-4818. PubMed ID: 32115754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.
    Bayless KJ; Davis GE
    J Biol Chem; 2001 Apr; 276(16):13483-9. PubMed ID: 11278897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
    Senger DR; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
    Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of transglutaminase reactive residues in human osteopontin and their role in polymerization.
    Christensen B; Zachariae ED; Scavenius C; Thybo M; Callesen MM; Kløverpris S; Oxvig C; Enghild JJ; Sørensen ES
    PLoS One; 2014; 9(11):e113650. PubMed ID: 25419572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
    Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
    BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and biological properties of osteopontin from bovine milk.
    Bayless KJ; Davis GE; Meininger GA
    Protein Expr Purif; 1997 Apr; 9(3):309-14. PubMed ID: 9126601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the phosphorylated sites of metabolically 32P-labeled osteopontin from cultured chicken osteoblasts.
    Salih E; Ashkar S; Gerstenfeld LC; Glimcher MJ
    J Biol Chem; 1997 May; 272(21):13966-73. PubMed ID: 9153260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.